8 Results for "

DCB

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "DCB" in MCE Product Catalog:

Cat. No.: HY-113953
CAS No.: 153088-73-4
Purity:  99.64%
Target:  

Caspase Apoptosis

Research Areas:  

Inflammation/Immunology

Z-Asp-CH2-DCB is an irreversible broad spectrum caspase inhibitor. Z-Asp-CH2-DCB also inhibits proteases with caspase-like activity. Z-D-CH2-DCB blocks the production of IL-1β, TNF-α, IL-6, and IFN-γ in staphylococcal enterotoxin B (SEB)-stimulated peripheral blood mononuclear cells (PBMC), and reduces SEB-1-stimulated T-cell proliferation in a dose-dependent manner. Z-Asp-CH2-DCB prevents SU5416-induced septal cell apoptosis and emphysema development .
loading...
    loading...
Cat. No.: HY-103561
CAS No.: 6971-97-7
Purity:  98.81%
Target:  

mGluR

Research Areas:  

Neurological Disease

DCB (3,3′-dichlorobenzaldazine) is an neutral allosteric modulator of themetabotropic glutamate receptor metabotropic glutamate receptor subtype 5 (mGluR5) . DCB blocks the positive allosteric regulation of mGluRs (mGluR5) with the help of 3,3′-difluorobenzaldazine (DFB). DCB shows the negative modulatory effect of 3,3′-dimethoxybenzaldazine (DMeOB) .
loading...
    loading...
Cat. No.: HY-111244
CAS No.: 87302-58-7
Target:  

CDK HSP

Research Areas:  

Others

DCB-3503 is an allosteric modulator of heat shock cognate protein HSC70 and an inhibitor of Cyclin D1. DCB-3503 inhibits Cyclin D1 translation by allosterically modulating the ATPase and chaperone activities of HSC70. DCB-3503 may inhibit malignancies such as hepatocellular carcinoma or breast cancer with elevated expression of cyclin D1 .
loading...
    loading...
Cat. No.: HY-111575
CAS No.: 723245-31-6
Target:  

SWI/SNF Complex

Research Areas:  

Cancer

DCB29 is a selective inhibitor of the BPTF bromodomain, with an IC50 value of 13.2 μM. DCB29 can be used for the study of the BPTF-related diseases (such as bladder cancer, colorectal cancer, melanoma, leukemia, and other cancers) .
loading...
    loading...
Cat. No.: HY-P992342

Target:  

Tim3

Research Areas:  

Cancer

DCB-8 is a specific inhibitor targeting human TIM-3. DCB-8 regulates T cell function, enhances cytokine secretion, and inhibits tumor growth in disease animal models. DCB-8 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-122324
CAS No.: 482-20-2
Synonyms: (+)-(S)-Tylophorine; DCB-3500; NSC-717335
Category:  

Apocynaceae Plants Tylophora

Target:  

Others

Tylophorine and its analogs are benzoindole alkaloids, most of which are derived from Garcinia plants. Tylophorine analogs all show potent growth inhibition against human hepatocellular carcinoma HepG2 and human nasopharyngeal carcinoma KB cell lines. Tylophorine analogs can also induce increased albumin expression and inhibit α-fetoprotein expression in HepG2 cells, and have the potential to induce HepG2 cell differentiation .
loading...
    loading...
Cat. No.: HY-103561R
CAS No.: 6971-97-7
Research Areas:  

Neurological Disease Cancer

DCB (Standard) is the analytical standard of DCB (HY-103561). This product is intended for research and analytical applications. DCB (3,3′-dichlorobenzaldazine) is an neutral allosteric modulator of the metabotropic glutamate receptor metabotropic glutamate receptor subtype 5 (mGluR5). DCB blocks the positive allosteric regulation of mGluRs (mGluR5) with the help of 3,3′-difluorobenzaldazine (DFB). DCB shows the negative modulatory effect of 3,3′-dimethoxybenzaldazine (DMeOB) .
loading...
    loading...
Cat. No.: HY-122324A
CAS No.: 111408-21-0
Synonyms: (-)-(R)-Tylophorine; (-)-DCB-3500; (-)-NSC-717335
(-)-Tylophorine ((-)-(R)-Tylophorine) is a potent cytotoxic agent with activity against both drug-sensitive and multidrug-resistant cancer cell lines. (-)-Tylophorine has been explored in biomedical research for its anticancer applications .
loading...
    loading...